AC105 in Patients With Acute Traumatic Spinal Cord Injury

NCT01750684 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated by the Sponsor due to insufficient enrollment.

Conditions

Acute Spinal Cord Injury

Interventions

DRUG: AC105
OTHER: Placebo

Sponsor

Acorda Therapeutics

Collaborators

[object Object]
[object Object]